SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051302
Filing Date
2020-11-05
Accepted
2020-11-05 16:07:44
Documents
71
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q Q3/2020 ctmx-10q_20200930.htm   iXBRL 10-Q 3076398
2 EX-10.1 - PFIZER AGREEMENT ctmx-ex101_357.htm EX-10.1 821581
3 EX-10.2 - BMS AGREEMENT ctmx-ex102_356.htm EX-10.2 587814
4 EX-10.3 - AMENDMENT NO. 1 WITH AMGEN ctmx-ex103_355.htm EX-10.3 34126
5 EX-31.1 ctmx-ex311_89.htm EX-31.1 19581
6 EX-31.2 ctmx-ex312_88.htm EX-31.2 19593
7 EX-32.1 ctmx-ex321_87.htm EX-32.1 10168
8 EX-32.2 ctmx-ex322_86.htm EX-32.2 10490
9 GRAPHIC gdjgwhsmemih000001.jpg GRAPHIC 6917
  Complete submission text file 0001564590-20-051302.txt   11243167

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA ctmx-20200930.xsd EX-101.SCH 61008
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctmx-20200930_cal.xml EX-101.CAL 49016
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctmx-20200930_def.xml EX-101.DEF 230044
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctmx-20200930_lab.xml EX-101.LAB 412782
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctmx-20200930_pre.xml EX-101.PRE 363543
15 EXTRACTED XBRL INSTANCE DOCUMENT ctmx-10q_20200930_htm.xml XML 1679586
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37587 | Film No.: 201290464
SIC: 2834 Pharmaceutical Preparations